|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:ARTeSYN_Biosolutions
gptkb:C_Technologies
gptkb:Polymem
gptkb:Spectrum_Laboratories
gptkb:TangenX_Technology
|
|
gptkbp:CEO
|
gptkb:Tony_J._Hunt
|
|
gptkbp:founded
|
1981
|
|
gptkbp:founder
|
gptkb:Alexander_Rich
|
|
gptkbp:headquartersLocation
|
gptkb:Waltham,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Repligen Corporation
|
|
gptkbp:industry
|
bioprocessing
|
|
gptkbp:netIncome
|
$104 million (2023)
|
|
gptkbp:numberOfEmployees
|
over 1,000
|
|
gptkbp:products
|
bioprocessing equipment
chromatography resins
protein A ligands
tangential flow filtration systems
|
|
gptkbp:publiclyTraded
|
true
|
|
gptkbp:revenue
|
$801 million (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:specializesIn
|
continuous manufacturing solutions
single-use bioprocessing technologies
|
|
gptkbp:stockExchange
|
gptkb:S&P_400
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ:RGEN
|
|
gptkbp:website
|
https://www.repligen.com/
|
|
gptkbp:bfsParent
|
gptkb:American_Chemical_Society_Repligen_Award_in_Chemistry_of_Biological_Processes
gptkb:Repligen_Award_in_Chemistry_of_Biological_Processes
gptkb:Avitide
|
|
gptkbp:bfsLayer
|
7
|